Teva Pharmaceutical (TEVA)
Investor Insights
Jun 4, 2026, 12:00 am This summary was created by AI, based on 2 opinions in the last 12 months.
Teva Pharmaceutical, traded under the symbol TEVA-N, has shown significant improvement, gaining 264% since the new CEO took office in January 2023, suggesting a robust turnaround for the company. After experiencing a rough period post-2002, recent positive financial results indicate that the company's performance is on the upswing. The headquarters in Israel underline its position as a large-cap player in the pharmaceutical industry. Under the current market conditions, Teva is ranked #1 in its ADR/CDR universe, benefiting from a rotation towards drug stocks. Its stock broke through the $21 barrier in September, continuing its upward trend with strong accumulation for the past six months, despite not currently offering a dividend. Analysts are optimistic about its prospects, projecting a price target of $34.50.
Teva Pharmaceutical (TEVA) Frequently Asked Questions
What is Teva Pharmaceutical stock symbol?
Teva Pharmaceutical is a American stock, trading under the symbol TEVA (previously TEVA-N on Stockchase) on the New York Stock Exchange (TEVA). It is usually referred to as NYSE:TEVA or TEVA
Is Teva Pharmaceutical a buy or a sell?
In the last year, 1 stock analyst published opinions about TEVA (previously TEVA-N on Stockchase). 1 analyst recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is BUY. Read the latest stock experts' ratings for Teva Pharmaceutical.
Is Teva Pharmaceutical a good investment or a top pick?
Teva Pharmaceutical was recommended as a Top Pick by Jonathen Wellum, B. Comm, B. Sc on 2000-12-15. Read the latest stock experts ratings for Teva Pharmaceutical.
Why is Teva Pharmaceutical stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for help on deciding if you should buy, sell or hold the stock.
Is Teva Pharmaceutical worth watching?
1 stock analyst on Stockchase covered Teva Pharmaceutical in the last year. It is a trending stock that is worth watching.
What is Teva Pharmaceutical stock price?
On 2026-06-04, Teva Pharmaceutical (TEVA) stock closed at a price of $34.43.
Financials 
Technical Analysis 
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
